Patents 322show all

  • 75
    C07D - Heterocyclic compounds
  • 73
    C07C - Acyclic or carbocyclic compounds
  • 47
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 36
    A61K - Preparations for medical, dental, or toilet purposes
  • 9
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 7
    A61F - Filters implantable into blood vessels
  • 5
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 3
    Y02A - Technologies for adaptation to climate change
  • 1
    B82Y - Specific uses or applications of nanostructures
  • 1
    C07H - Sugars

Clinical Trials 6show all

2N/A2Phase 21Phase 11Phase 1/Phase 2

SEC Filings show all


4
D

Contact Information

Madison, WI
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-11-07$28,050,000$28,050,000Equity
2010-07-30$15,000,000$15,000,000Equity
2009-08-20$9,000,000$9,000,000Equity, Security to be Acquired
2006-11-15Unknown Unknown Other (Paper Filing)

Key Executives

  • Christopher A. Kroeger
    Executive Officer, Director
  • Reza Mazhari
    Executive Officer
  • John Barrett
    Director
  • Jeff Clark
    Director
  • Robert Garland
    Director
  • Charles Sanders
    Director
  • James Barrett
    Director
  • Doug Cowart
    Director
  • John Reardon
    Director
  • Vince Kalish
    Executive Officer
  • Gary Stiles
    Director
  • Anthony Johnson
    Director
  • Peter Thompson
    Director